Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Nov 8, 2022, after the close
10-Q filed Nov 9, 2022, 40 days after period end · 0001171843-22-007249
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $26.92M | $29.66M | $24.04M | $27.42M |
| Net Income | -$3.41M | -$170.00K | -$1.10M | -$2.62M |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.08 |
| $0.00 |
| -$0.03 |
| -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
